Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Net Income (Quarterly) : -14.56M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.56M |
| March 31, 2026 | -8.681M |
| December 31, 2025 | -13.03M |
| September 30, 2025 | -9.693M |
| June 30, 2025 | -8.828M |
| March 31, 2025 | -4.577M |
| December 31, 2024 | -3.343M |
| September 30, 2024 | -17.46M |
| June 30, 2024 | -2.254M |
| March 31, 2024 | -3.668M |
| December 31, 2023 | -6.770M |
| September 30, 2023 | -5.875M |
| June 30, 2023 | -5.011M |
| Date | Value |
|---|---|
| March 31, 2023 | -6.308M |
| December 31, 2022 | -3.557M |
| September 30, 2022 | -3.854M |
| June 30, 2022 | -3.986M |
| March 31, 2022 | -3.438M |
| December 31, 2021 | -3.092M |
| September 30, 2021 | -1.443M |
| June 30, 2021 | -5.030M |
| March 31, 2021 | -0.892M |
| September 30, 2020 | -0.8762M |
| June 30, 2020 | 7.479M |
| March 31, 2020 | 0.8265M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.337B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.56M |
| EPS Diluted (Quarterly) | -0.153 |
| Enterprise Value | 3.203M |
| Earnings Yield | -104.3% |
| Normalized Earnings Yield | -104.32 |